Literature DB >> 23242811

Access to patient-centered medical home among Ohio's Children with Special Health Care Needs.

Elizabeth J Conrey1, Dazar Seidu, Norma J Ryan, Dj Sam Chapman.   

Abstract

Medical homes deliver primary care that is accessible, continuous, comprehensive, family centered, coordinated, compassionate and culturally effective. Children with special health care needs (CSHCN) require a wide range of support to maintain health, making medical home access particularly important. We sought to understand independent risk factors for lacking access. We analyzed Ohio, USA data from the National Survey of Children with Special Health Care Needs (2005-2006). Among CSHCN, 55.6% had medical home access. The proportion achieving each medical home component was highest for having a personal doctor/nurse and lowest for receiving coordinated care, family-centered care and referrals. Specific subsets of CSHCN were significantly and independently more likely to lack medical home access: Hispanic (AOR=3.08), moderate/high severity of difficulty (AOR=2.84), and any public insurance (AOR=1.60). Efforts to advance medical home access must give special attention to these CSHCN populations and improvements must be made to referral access, family-centered care, and care coordination.

Entities:  

Keywords:  Children with special health care needs; Hispanic; Medicaid; healthcare access; insurance; medical home

Mesh:

Year:  2012        PMID: 23242811     DOI: 10.1177/1367493512456111

Source DB:  PubMed          Journal:  J Child Health Care        ISSN: 1367-4935            Impact factor:   1.979


  2 in total

Review 1.  Disparities, race/ethnicity and access to pediatric kidney transplantation.

Authors:  Sandra Amaral; Rachel Patzer
Journal:  Curr Opin Nephrol Hypertens       Date:  2013-05       Impact factor: 2.894

2.  Racial and ethnic differences in pediatric access to preemptive kidney transplantation in the United States.

Authors:  R E Patzer; B A Sayed; N Kutner; W M McClellan; S Amaral
Journal:  Am J Transplant       Date:  2013-06-03       Impact factor: 8.086

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.